Document is current

Article History

Received: 3 March 2021

Accepted: 3 June 2021

First Online: 16 June 2021

Declarations

:

: All protocols were approved by an institutional review board (Shulman Associates IRB; IRB approval number 201202559, approval date April 11, 2012; IRB approval number 201208471, approval date November 16, 2012) and all patients provided written informed consent prior to the study onset. These studies were conducted in accordance with the International Council for Harmonisation, Good Clinical Practice guidelines, the ethical concepts of the Declaration of Helsinki, and/or all applicable federal and local regulations.

: This manuscript does not show or report personal data such as individual details or images; therefore, consent for publication is not applicable.

: MSA reports roles as Vice President of the American Association of Gynecologic Laparoscopists and Editor-in-Chief of the <i>Journal of Endometriosis and Pelvic Pain Diseases</i>. ES has received research support from AbbVie, has served on medical advisory boards for AbbVie and Dot Laboratories, and has been a member of the speakers’ bureau for AbbVie and Ferring Laboratories. HST has received research support from AbbVie, DotLab, and Pfizer and has served as a consultant for AbbVie. MCS, KG, HW, and HI are AbbVie employees and hold stock or own stock options.